MHY884 is a tyrosinase inhibitor that suppresses UVB-induced activation of NF-kappaB signaling pathway through the downregulation of oxidative stress. MHY884 suppresses oxidative stress in the melanoma cells and attenuates UVB-induced oxidative stress, resulting in reduced NF-kappaB activity in irradiated mice. MHY884 is promising for research of UVB-induced skin damage[1].
Molekulargewicht:
323.79
CAS Nummer:
[1393371-35-1]
Formel:
C15H14ClNO3S
Target-Kategorie:
NF-kappaB,Tyrosinase
Anwendungsbeschreibung:
MCE Product type: Reference compound1
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten
